Clinical trials
MG clinical trials
Below are recruiting mg clinical trials, each written for real people, not researchers. We’re tracking 936 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07499804RecruitingPhase 4
Tadalafil for thicker uterine lining before embryo transfer
This study tests whether tadalafil (a medication often used for erectile dysfunction) can help thicken the lining of the uterus before transferring a frozen embryo. If you have good quality frozen embryos, this may improve your chance of a successful pregnancy.
Banī Suwayf, Beni Suweif GovernorateAges 18–43 - NCT07499817RecruitingPhase 3
Effect of pentoxifylline on womb lining and frozen embryo transfer
This trial tests if a medication called pentoxifylline can help thicken the womb lining and improve success rates for frozen embryo transfers. It may be an option for people with a thin womb lining before their procedure.
Banī Suwayf, Beni Suweif GovernorateAges 18–43 - NCT05969795RecruitingPhase 1
Natural embryo transfer with or without progesterone support
This Phase 1 study compares pregnancy outcomes, especially live birth, when using a natural-cycle frozen embryo transfer with an embryo that is genetically euploid (normal chromosome number) versus doing transfers without luteal (progesterone) phase support. It may help determine whether adding progesterone around ovulation improves the chance of a live birth.
Abu DhabiAges 18–40 - NCT06763172RecruitingPhase 4
Caffeine's effect on learning in healthy adults
This study uses brain scans to see how caffeine affects the way we learn from rewards and punishments. You may be eligible if you are a healthy adult who drinks a moderate amount of caffeine daily.
Charlestown, MassachusettsAges 18–45 - NCT04513626RecruitingPhase 2
HIV trial testing doravirine plus raltegravir in adults
This Phase 2 trial studies whether switching to a combination of doravirine and raltegravir can safely maintain control of HIV in adults whose virus is already well suppressed. It may help people who are currently on stable HIV treatment and are not resistant to these specific medicines.
Paris, Île-de-France RegionAges 18 years+ - NCT07490353RecruitingPhase 1
Can psilocybin help treat loss of pleasure?
This trial tests if psilocybin, a psychedelic substance, can improve the ability to feel pleasure (anhedonia) in people with depression who are not taking antidepressants. It also includes healthy volunteers as a comparison group.
Vienna, State of ViennaAges 18–55 - NCT07484217RecruitingPhase 3
Testing solriamfetol for depression with daytime sleepiness
This study tests if the drug solriamfetol can help people with major depression who also feel very tired during the day. It aims to improve both mood and daytime sleepiness.
Tucson, ArizonaAges 18–65 - NCT07481955RecruitingPhase 2
A study of chlorhexidine and metronidazole plus FB301 for bacterial vaginosis
This trial tests a pre-treatment with chlorhexidine and/or metronidazole before a new drug called FB301 in women with bacterial vaginosis (BV). It aims to see if this combination is safe and works well.
Berlin, State of BerlinAges 18–45 - NCT06472219RecruitingPhase 3
PREDICATE trial for serious lung infections
This trial tests a new approach to treating serious respiratory infections in hospitalized adults. It aims to see if a targeted strategy works better than standard care while avoiding extra risks.
Hong KongAges 18 years+ - NCT07482943RecruitingPhase 4
Dapagliflozin for heart function after Fontan procedure
This trial tests whether dapagliflozin, a diabetes drug that also helps the heart, can improve exercise ability and heart function in people who have had the Fontan procedure for a single ventricle heart defect.
Hong KongAges 12 years+ - NCT03437057Recruiting
Aspirin after kidney stone treatment to prevent clotting
This study looks at whether taking a daily aspirin medicine during and after extracorporeal shockwave treatment for a kidney stone helps keep the blood from “clumping” too much. It will compare different maintenance approaches while monitoring safety, especially bleeding risk.
Clermont-FerrandAges 18 years+ - NCT07476482Enrolling by invitation
Shared decision-making during planned C-section under spinal anesthesia
This trial tests whether involving you in decisions during your planned C-section can improve your experience. You will be awake under spinal anesthesia and the study focuses on helping you feel more in control.
AlexandriaAges 18 years+ - NCT07478003RecruitingPhase 3
Early steroid for severe heart attacks before reaching the hospital
This study tests whether giving a high dose of a steroid medication (glucocorticoid) early, before reaching the hospital, can help people having a severe type of heart attack called STEMI. If you are having this specific heart attack and meet the criteria, receiving this medication might improve your recovery.
AalborgAges 18 years+ - NCT07473310RecruitingPhase 4
Shockwave therapy or solifenacin for overactive bladder in women
This trial compares a new treatment (low-intensity shockwave therapy) with a standard medication (solifenacin) to see which works better for women with overactive bladder (OAB). Overactive bladder means you feel a sudden, strong need to urinate, often have to go frequently, or may leak urine. The study aims to find a more effective or better-tolerated option.
Al Mansurah, Dakahlia GovernorateAges 18 years+ - NCT07471555Enrolling by invitation
Vascular access and intraosseous study for nursing students
This trial tests a teaching method for inserting a special needle into bone (intraosseous access) and regular IV lines. It is only for 4th year nursing students.
Valencia, ValenciaAges 18 years+ - NCT07470151Recruiting
Study of EVM18001 for hard-to-treat autoimmune diseases
This trial tests a new treatment, EVM18001, for people with lupus, myasthenia gravis, or systemic sclerosis that hasn't improved with standard therapies. It aims to see if this therapy can help control the disease.
Wuhan, HubeiAges 18–70 - NCT07461532Recruiting
Apixaban for late portal vein clot after spleen surgery
This trial is testing whether a blood thinner called apixaban can treat a blood clot in the main vein to the liver (portal vein) that appeared more than a year after spleen surgery in people with cirrhosis. It compares apixaban to a low-dose aspirin to see if one works better with fewer side effects.
Yangzhou, JiangsuAges 18 years+ - NCT07461545Recruiting
Apixaban for late portal vein clot after spleen surgery
This trial tests if apixaban, a blood thinner, is more effective than aspirin at treating blood clots in the portal vein that form more than a year after laparoscopic spleen removal in people with cirrhosis and an enlarged spleen.
Yangzhou, JiangsuAges 18 years+ - NCT07462156Recruiting
AI Tool for Dental Students to Self-Assess Tooth Preparations
This trial tests a new AI-powered digital tool that helps dental students self-check their tooth preparations. If you are a third-year preclinical dental student who has completed the basic course but hasn't used digital assessment tools before, you may be able to join this study to see if the AI tool improves your skills.
El AlameinAges 18–20 - NCT07437768Enrolling by invitation
Vonoprazan test for acid reflux that doesn't respond to standard medicine
This trial tests a medicine called vonoprazan for people whose acid reflux symptoms (like heartburn or coughing) don't get better with usual treatment. It aims to see if vonoprazan can help control those symptoms.
New Taipei City, TaiwanAges 20–75 - NCT06811831RecruitingEarly Phase 1
Mactientan for chest pain from small heart artery problems
This trial tests if mactientan, a blood vessel relaxer, can improve chest pain in people with coronary microvascular angina—where small heart arteries don't work right even though larger ones are clear. It aims to help those with ongoing angina symptoms.
Beijing, Beijing MunicipalityAges 18–75 - NCT07433257Recruiting
Steroid injection for carpal tunnel with diabetes
This study tests if a steroid injection in the wrist helps people with carpal tunnel syndrome, comparing results between those with and without type 2 diabetes. If you have mild to moderate carpal tunnel and either well-controlled diabetes or no diabetes, you may be able to join.
Istanbul, IstanbulAges 18–75 - NCT07432373Recruiting
Comparing clot-busting drugs for lung infections
This trial tests two combinations of medicines for people with infected fluid around the lung that isn't draining well through a chest tube. The goal is to see which combination works better to clear the infection and improve recovery.
Cheras, Kuala LumpurAges 18 years+ - NCT06814223RecruitingPhase 4
Can antibiotics prevent catheter infections in dialysis patients?
This study tests if giving antibiotics before placing a dialysis catheter can prevent infections. It may help people with heart conditions or those who need a catheter in the leg.
Nahariya, IsraelAges 18 years+
Hear when a new MG trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for mg?
- Yes. Clin2 currently lists 936 recruiting mg studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a mg trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a mg trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.